ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
발진 시장 규모는 향후 수년간 안정된 성장이 예상될 예정입니다. 예측 기간 동안의 성장은 연구 개발에 대한 투자 증가, 바이러스 및 박테리아 감염의 증가, 원격 의료에 대한 강조 증가, 정부 이니셔티브 확대, 경구용 의약품에 대한 수요 증가에 기인할 수 있습니다.
바이러스 감염의 유병률 증가는 향후 수년간 발진 시장의 성장을 이끌 것으로 예측됩니다. 기후 변화, 인구의 면역력 저하 등의 요인이 바이러스 감염증의 빈도 상승에 기여하고 있습니다. 역활성화의 시그널 전달, 바이러스에 대한 몸의 싸움을 나타내는 것에 의한 진단 보조 등의 역할을 완수합니다. 예를 들어, 미국 질병통제예방센터(CDC)에 따르면 2022년부터 2024년까지 최근 파보바이러스 B19 감염을 나타내는 IgM 항체를 보유한 사람의 비율은 3% 미만을 유지했지만 2024년 6월에는 10%로 급증했습니다.
발진 시장에서 사업을 전개하는 기업은 백신이나 항바이러스 치료제의 근육내(IM) 투여 등 새로운 치료법의 개발에 약진하고 있습니다. 주사기와 주사 바늘을 사용하여 백신과 약물을 근육 조직에 직접 투여하는 이 방법은 혈류로의 신속한 흡수를 보장합니다. 근육 내의 풍부한 혈액 공급을 이용함으로써, IM 투여는 치료나 면역 반응을 촉진시켜, 치료 효과를 향상시킵니다. 예를 들어, 2023년 3월, Merck&Co.Inc.는 FDA가 MMRV 백신-MR II, VARIVAX, ProQuad의 IM 투여 경로를 승인했다고 발표했습니다. 이 방법은 다른 투여 방법과 비교하여 이러한 생 바이러스 백신의 안정성과 효능이 높고 심각한 바이러스 감염을 예방하는 공중 보건 노력을 강화하는 데 중요한 단계입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 발진 시장의 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 발진 시장 : 성장률 분석
세계의 발진 시장 실적 : 규모와 성장(2019-2024년)
세계의 발진 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 발진 전체 시장(TAM)
제6장 시장 세분화
세계의 발진 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
박테리아
바이러스
기타
세계의 발진 시장 : 치료별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
국소 치료
전신 치료
지지 치료
세계의 발진 시장 : 진단 방법별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
임상 검사
실험실 검사
영상 기술
세계의 발진 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
홍역
풍진
감염성 홍반
소아 돌발성 발진
세계의 발진 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
홈케어
전문센터
기타
세계의 발진 시장 : 박테리아 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
성홍열
수막 구균 혈증
포도상구균 화상피부증후군(SSSS)
라임병
결핵 관련 홍반
세계의 발진 시장 : 바이러스 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
홍역(풍진)
풍진(독일 홍역)
수두(수두)
수족구병(대샃포진)
수족구병
파보 바이러스 B19(홍반 감염증/제5군 질병)
뎅기열 발진
지카바이러스 발진
세계의 발진 시장 : 기타 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
약제 유발성 홍반(과민 반응)
자가면역 관련 발진(루프스, 가와사키병)
알레르기성 피부염 관련 홍반
홍반을 유발하는 곰팡이 감염
환경 및 독소 유발성 홍반
제7장 지역별/국가별 분석
세계의 발진 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 발진 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
발진 시장 : 경쟁 구도
발진 시장 : 기업 프로파일
F. Hoffmann-La Roche Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck & Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Sanofi SA : 개요, 제품 및 서비스, 전략 및 재무 분석
Abbott Laboratories : 개요, 제품 및 서비스, 전략 및 재무 분석
GlaxoSmithKline plc : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Serum Institute of India Pvt. Ltd.
Takeda Pharmaceutical Company Limited
Amgen Inc.
Daiichi Sankyo Company Limited
Biological E. Limited
Zydus Lifesciences Limited
Bio Farma
Meridian Bioscience Inc.
West-Ward Pharmaceutical Corp.
Trinity Biotech plc
Biosynth Srl
Creative Diagnostics
Taj Pharmaceuticals Limited
TestLine Clinical Diagnostics sro
The Native Antigen Co. Ltd.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
발진 시장(2029년) : 새로운 기회를 제공하는 국가
발진 시장(2029년) : 새로운 기회를 제공하는 부문
발진 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
KTH
영문 목차
영문목차
Exanthema is a term used to describe a widespread skin rash or eruption, often resulting from a viral infection such as measles, rubella, or chickenpox (varicella). It plays a crucial role in diagnosing and identifying viral illnesses, as the rash's specific characteristics can help healthcare professionals determine the cause of the infection and decide on the most suitable treatment and management approaches.
The primary types of exanthema include bacterial, viral, and other forms. Bacterial exanthema is caused by infections from bacteria such as Streptococcus or Staphylococcus, leading to skin rashes. Treatment options involve topical medications, systemic therapies, and supportive care, with diagnostic methods including clinical examination, laboratory tests, and imaging techniques. Common conditions associated with exanthema include rubeola, rubella, erythema infectiosum, and roseola infantum. These diagnostic and treatment approaches are used by various healthcare providers, including hospitals, homecare services, and specialty centers.
The exanthema market research report is one of a series of new reports from The Business Research Company that provides exanthema market statistics, including the exanthema industry global market size, regional shares, competitors with the exanthema market share, detailed exanthema market segments, market trends, and opportunities, and any further data you may need to thrive in the exanthema industry. This exanthema market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The exanthema market size has grown steadily in recent years. It will grow from $2.18 billion in 2024 to $2.28 billion in 2025 at a compound annual growth rate (CAGR) of 4.7%. The growth during the historical period can be attributed to factors such as higher healthcare spending, increased awareness about vaccination, rising disposable incomes, greater understanding of skin disorders, and a stronger focus on early detection.
The exanthema market size is expected to see steady growth in the next few years. It will grow to $2.71 billion in 2029 at a compound annual growth rate (CAGR) of 4.4%. The growth during the forecast period can be attributed to increased investments in research and development, a higher prevalence of viral and bacterial infections, a growing emphasis on telemedicine, expanding government initiatives, and a rising demand for oral medications. Key trends during this period include advancements in treatment approaches, innovations in diagnostic techniques, technological progress, breakthroughs in medical research and technology, and the development of assistive technologies.
The increasing prevalence of viral infections is expected to drive the growth of the exanthema market in the coming years. Viral infections are illnesses caused by viruses that invade and replicate within the body's cells, resulting in various symptoms and diseases. Factors such as global travel, urbanization, climate change, and weakened immunity in populations are contributing to the rising frequency of viral infections. As more cases present with skin rashes, there is a growing need for effective exanthema treatments. Exanthema, which serves as a visible immune response to viral infections, plays a role in expelling pathogens, signaling immune activation, and assisting in diagnosis by showing the body's fight against the virus. For example, according to the Centers for Disease Control and Prevention (CDC), between 2022 and 2024, the percentage of individuals with IgM antibodies, which indicate a recent Parvovirus B19 infection, remained below 3%, but surged to 10% by June 2024. The most significant rise occurred among children aged 5-9, where the prevalence increased from 15% to 40% during this period. As a result, the increasing prevalence of viral infections is driving the growth of the exanthema market.
Companies operating in the exanthema market are making strides in developing new therapeutics, including intramuscular (IM) administration of vaccines and antiviral treatments. This method, which involves delivering vaccines or medications directly into the muscle tissue via a syringe and needle, ensures quick absorption into the bloodstream. By leveraging the rich blood supply in the muscles, the IM administration prompts a therapeutic or immune response, improving the efficacy of the treatment. For example, in March 2023, Merck & Co. Inc. announced that the FDA had approved the IM administration route for its MMRV vaccines-M-M-R II, VARIVAX, and ProQuad. This method offers greater stability and efficacy for these live-virus vaccines compared to other administration methods, making it a key step in enhancing public health efforts to prevent severe viral infections.
In September 2024, Organon, a US-based healthcare company, acquired Dermavant Sciences Ltd. for $1.2 billion. Dermavant Sciences is a clinical-stage biopharmaceutical company that focuses on developing innovative therapeutics in immunodermatology. This acquisition strengthens Organon's position in the dermatology field and aligns with its objectives to expand its portfolio with cutting-edge therapies.
Major players in the exanthema market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Sanofi SA, Abbott Laboratories, GlaxoSmithKline plc, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Company Limited, Amgen Inc., Daiichi Sankyo Company Limited, Biological E. Limited, Zydus Lifesciences Limited, Bio Farma, Meridian Bioscience Inc., West-Ward Pharmaceutical Corp., Trinity Biotech plc, Biosynth Srl, Creative Diagnostics, Taj Pharmaceuticals Limited, TestLine Clinical Diagnostics s.r.o., The Native Antigen Co. Ltd., and QED Bioscience Inc.
North America was the largest region in the exanthema market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in exanthema report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the exanthema market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The exanthema market consists of revenues earned by entities by providing services such as antiviral treatment services, vaccination services, and diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The exanthema market also includes sales of topical corticosteroids, antihistamines, immunosuppressants, antiviral medications, and moisturizers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Exanthema Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on exanthema market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for exanthema ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The exanthema market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Types: Bacterial; Viral; Other Types
2) By Treatment: Topical Treatments; Systemic Treatments; Supportive Care
3) By Diagnosis Method: Clinical Examination; Laboratory Tests; Imaging Techniques
4) By Application: Rubeola; Rubella; Erythema Infectiosum; Roseola Infantum
5) By End-Users: Hospitals; Homecare; Specialty Centers; Other End-Users
3) By Other Types of Exanthema: Drug-Induced Exanthema (Hypersensitivity Reactions); Autoimmune-Related Exanthema (Lupus, Kawasaki Disease); Allergic Dermatitis-Related Exanthema; Fungal Infections Leading to Exanthema; Environmental and Toxin-Induced Exanthema
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Exanthema Market Characteristics
3. Exanthema Market Trends And Strategies
4. Exanthema Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Exanthema Growth Analysis And Strategic Analysis Framework
5.1. Global Exanthema PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Exanthema Market Growth Rate Analysis
5.4. Global Exanthema Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Exanthema Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Exanthema Total Addressable Market (TAM)
6. Exanthema Market Segmentation
6.1. Global Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bacterial
Viral
Other Types
6.2. Global Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Treatments
Systemic Treatments
Supportive Care
6.3. Global Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinical Examination
Laboratory Tests
Imaging Techniques
6.4. Global Exanthema Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Rubeola
Rubella
Erythema Infectiosum
Roseola Infantum
6.5. Global Exanthema Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare
Speciality Centres
Other End-Users
6.6. Global Exanthema Market, Sub-Segmentation Of Bacterial Exanthema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Scarlet Fever
Meningococcemia
Staphylococcal Scalded Skin Syndrome (SSSS)
Lyme Disease
Tuberculosis-Associated Exanthema
6.7. Global Exanthema Market, Sub-Segmentation Of Viral Exanthema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
